ALPS Medical Breakthroughs ETF (USD) (SBIO, US00162Q5936)

(%)

34,45 USD

NAV pro Aktie

Exchange Traded Funds (ETF)

Fondstyp

Equity

Investitionsobjekt

Biotech

Sektor

USA

Geographie

29/12/2014

Startdatum

110,24 Mio. USD

Gesamtes Fondsvermögen

0.5 %

Gesamtkostenquote

S-Network Medical Breakthroughs Index

Benchmark

ALPS Advisors

Anbieter

110,24 Mio. USD

Aktien-Anlageklasse Volumen

1 Wiederholungen pro Jahr

Ausschüttung von Dividenden

Replikationsmethode

Mindestschwelle

Split

US00162Q5936

ISIN

SBIO

Ticker

CEOJMS

CFI

Entdecken Sie die umfangreichste Datenbank

800 000

Anleihen weltweit

Über 400

Kursquellen

80 000

Aktien

9 000

ETF

Verwalten Sie Ihr Portfolio auf effizienteste Weise

Bond-Screener

Watchlist

Excel-Add-In

Zugang erhalten

Kurse (SBIO)

Rendite auf 03/05/2024

YTD

5,03 %
1M

0,25 %
3M

2,87 %
6M

31,97 %
1J

11,15 %
3J

-30,48 %
5J

-0,39 %
10J

-

Zum Börsenpreis einschliesslich Einkommenszahlungen

Kurs-Dynamik

Struktur auf 03/05/2024

Wertpapier	Wertpapier
Viking Therapeutics Inc.	5,13%
Cerevel Therapeutics Holdings Inc.	4,9%
Vaxcyte Inc.	4,52%
REVOLUTION Medicines Inc.	4,2%
Alpine Immune Sciences Inc.	2,69%
Alkermes PLC	2,55%
Crinetics Pharmaceuticals Inc.	2,33%
Axsome Therapeutics Inc.	2,25%
SpringWorks Therapeutics Inc.	2,11%
Xenon Pharmaceuticals Inc.	2,09%
Ideaya Biosciences Inc.	1,97%
Summit Therapeutics Inc.	1,96%
Immunocore Holdings PLC	1,9%
ACADIA Pharmaceuticals Inc.	1,78%
Merus NV	1,78%
Arcellx Inc.	1,77%
Celldex Therapeutics Inc.	1,74%
MoonLake Immunotherapeutics	1,72%
Rhythm Pharmaceuticals Inc.	1,67%
Corcept Therapeutics Inc.	1,61%
Vera Therapeutics Inc.	1,51%
Denali Therapeutics Inc.	1,51%
Vericel Corp.	1,47%
Intellia Therapeutics Inc.	1,44%
Arvinas Inc.	1,42%
Keros Therapeutics Inc.	1,38%
Geron Corp.	1,36%
Avidity Biosciences Inc.	1,34%
Deciphera Pharmaceuticals Inc.	1,3%
Agios Pharmaceuticals Inc.	1,23%
Galapagos NV	1,22%
Syndax Pharmaceuticals Inc.	1,19%
Edgewise Therapeutics Inc.	1,15%
Catalyst Pharmaceuticals Inc.	1,1%
Inhibrx Inc.	1,03%
Zai Lab Ltd.	1,02%
Kura Oncology Inc.	1%
Protagonist Therapeutics Inc.	0,97%
Day One Biopharmaceuticals Inc.	0,95%
Morphic Holding Inc.	0,95%
Xencor Inc.	0,94%
Arcus Biosciences Inc.	0,9%
Neumora Therapeutics Inc.	0,89%
Vir Biotechnology Inc.	0,89%
Tarsus Pharmaceuticals Inc.	0,88%
Soleno Therapeutics Inc.	0,87%
4D Molecular Therapeutics Inc.	0,83%
Ironwood Pharmaceuticals Inc.	0,81%
Verona Pharma PLC	0,8%
Prothena Corp. PLC	0,78%
Mirum Pharmaceuticals Inc.	0,76%
MannKind Corp.	0,75%
Akero Therapeutics Inc.	0,7%
MiMedx Group Inc.	0,69%
MacroGenics Inc.	0,62%
Liquidia Corp.	0,62%
Viridian Therapeutics Inc.	0,61%
ARS Pharmaceuticals Inc.	0,59%
OPKO Health Inc.	0,58%
BioCryst Pharmaceuticals Inc.	0,58%
89bio Inc.	0,55%
Pliant Therapeutics Inc.	0,53%
Zentalis Pharmaceuticals Inc.	0,53%
Kiniksa Pharmaceuticals Ltd.	0,51%
Aurinia Pharmaceuticals Inc.	0,47%
Arcturus Therapeutics Holdings Inc.	0,46%
Disc Medicine Inc.	0,46%
AnaptysBio Inc.	0,45%
Savara Inc.	0,4%
Olema Pharmaceuticals Inc.	0,37%
Aerovate Therapeutics Inc.	0,36%
Compass Pathways PLC	0,35%
Mineralys Therapeutics Inc.	0,34%
Allogene Therapeutics Inc.	0,33%
Alector Inc.	0,33%
Fulcrum Therapeutics Inc.	0,3%
Travere Therapeutics Inc.	0,3%
Biomea Fusion Inc.	0,28%
Replimune Group Inc.	0,27%
ACELYRIN Inc.	0,27%
iTeos Therapeutics Inc.	0,27%
Aura Biosciences Inc.	0,25%
Atea Pharmaceuticals Inc.	0,21%
Enanta Pharmaceuticals Inc.	0,2%
Anavex Life Sciences Corp.	0,2%
Inozyme Pharma Inc.	0,19%
RAPT Therapeutics Inc.	0,18%
Vanda Pharmaceuticals Inc.	0,18%
Amylyx Pharmaceuticals Inc.	0,09%
Reneo Pharmaceuticals Inc.	0,04%
Cash and Equivalents	0,03%
Chinook Therapeutics Inc.	0%
Radius Health CVR	0%
Azn Ln - Cvr	0%
AstraZeneca PLC	0%

Alle anzeigen Verstecken

Struktur in Excel herunterladen